Inventor
MARIOLA FOTIN-MLECZEK
Inventor
DE
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
Y02ATechnologies for adaptation to climate change21%
C07KPeptides17%
C12NMicroorganisms or enzymes14%
PatentTitleYear
12,447,209Combination of vaccination and inhibition of the PD-1 pathway202512,227,549RNA encoding a therapeutic protein202512,178,863Combination of vaccination and OX40 agonists202411,690,910Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen202311,596,699RNA encoding an antibody202311,559,570Prime-boost regimens involving administration of at least one mRNA construct202311,458,193Combination of vaccination and inhibition of MHC class I restricted antigen presentation202211,458,195Combination of vaccination and inhibition of the PD-1 pathway2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to CUREVAC AG (3)· patent assignee history
2022–2025Based in DE· patent location history
2023–2025Patents assigned to CureVac SE (6)· patent assignee history
2025Patents assigned to Cure Vac SE (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CureVac SE | 6 | 2023–2025 |
| CUREVAC AG | 3 | 2022–2024 |
| Cure Vac SE | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 8 | 2022–2025 |